Literature DB >> 10438571

Cytokines modulate integrin alpha(v)beta(3)-mediated human endothelial cell adhesion and calcium signaling.

C H Yeh1, H C Peng, T F Huang.   

Abstract

Angiogenesis is a complex process regulated by the interactions of endothelial cells with cytokines and the adhesive protein matrix. The cytokines basic fibroblast growth factor (bFGF) and tumor necrosis factor-alpha (TNF-alpha) are two of the modulators of angiogenesis. One mechanism by which these cytokines induce their effects may be through the regulation of integrin adhesion receptor activity, in particular, alpha(v)beta(3). In this study, we examined the ability of these angiogenic factors to modulate the adhesion of human umbilical vein endothelial cells (HUVECs) to immobilized disintegrins (i.e., rhodostomin and arietin), which are specific in antagonizing integrin alpha(v)beta(3) in cells. As these disintegrins were immobilized as substrates, they acted as agonists to induce HUVEC adhesion in a dose- and alpha(v)beta(3)-dependent manner. In addition, adhesion also triggered a sustained increase of intracellular free calcium. Furthermore, bFGF-primed HUVECs potentiated, but TNF-alpha primed cells attenuated, about 50% adhesion events and calcium signaling triggered by immobilized disintegrin compared to naive cells, respectively. The mechanisms of modulating alpha(v)beta(3)-dependent HUVEC adhesion by cytokines may be related to changes of integrin alpha(v)beta(3) conformation, as demonstrating the antagonistic effect of Mn(2+) on decreased adhesion by TNF-alpha pretreatment, and confirmed with flow cytometric analysis probed by anti-LIBS1 mAb. However, cytokine pretreatment did not alter the expression of this integrin on the cell surface, as determined by flow cytometry. Phosphoinositide-3 kinase may be one of the signaling molecules involved in the enhanced adhesion of bFGF-primed cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438571     DOI: 10.1006/excr.1999.4560

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

1.  Ultrastructural immunolocalization of basic fibroblast growth factor in endothelial cells: morphologic evidence for unconventional secretion of a novel protein.

Authors:  Ranan Gulhan Aktas; Robert J Kayton
Journal:  J Mol Histol       Date:  2011-08-10       Impact factor: 2.611

2.  Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.

Authors:  Hong Zhang; Andrew C Issekutz
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 3.  Antiangiogenesis -- therapeutic strategies and clinical implications for brain tumors.

Authors:  V K Puduvalli; R Sawaya
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.506

Review 4.  A new perspective in sepsis treatment: could RGD-dependent integrins be novel targets?

Authors:  Danielle Nader; Gerard F Curley; Steven W Kerrigan
Journal:  Drug Discov Today       Date:  2020-10-06       Impact factor: 7.851

5.  Activation of the ERK1/2 signaling pathway during the osteogenic differentiation of mesenchymal stem cells cultured on substrates modified with various chemical groups.

Authors:  Bing Bai; Jin He; Yan-Shu Li; Xiu-Mei Wang; Hong-Jun Ai; Fu-Zhai Cui
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.